Table of Contents
ISRN Stem Cells
Volume 2013 (2013), Article ID 784541, 12 pages
http://dx.doi.org/10.1155/2013/784541
Review Article

The Systems Biology of Stem Cell Released Molecules—Based Therapeutics

BioRegenerative Sciences, Inc., 2658 Del Mar Heights Road, Suite 416, San Diego, CA 92014, USA

Received 20 February 2013; Accepted 2 April 2013

Academic Editors: A. Chapel and B. Rogister

Copyright © 2013 Greg Maguire and Peter Friedman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. K. Baillie, M. W. Barnett, and K. R. Upton, “Somatic retrotransposition alters the genetic landscape of the human brain,” Nature, vol. 479, pp. 534–537, 2011. View at Google Scholar
  2. J. Kaiser, “Genetic influences on disease remain hidden,” Science, vol. 338, pp. 1016–1017, 2012. View at Google Scholar
  3. A. Magi, L. Tattini, M. Benelli, B. Giusti, R. Abbate, and S. Ruffo, “WNP: a novel algorithm for gene products annotation from weighted functional networks,” PLoS ONE, vol. 7, no. 6, Article ID e38767, 2012. View at Google Scholar
  4. G. Maguire, “Using a systems-based approach for the development of diagnostics,” Expert Review of Molecular Diagnostics. In press.
  5. J. A. DiMasi, “Risks in new drug development: approval success rates for investigational drugs,” Clinical Pharmacology & Therapeutics, vol. 69, no. 5, pp. 297–307, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. H. Munos and W. W. Chin, “How to revive breakthrough innovation in the pharmaceutical industry,” Science Translational Medicine, vol. 3, no. 89, Article ID 89cm16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. McNamee and F. D. Ledley, “Patterns of technological innovation in biotech,” Nature Biotechnology, vol. 30, pp. 937–943, 2012. View at Google Scholar
  8. M. K. Hellerstein, “Exploiting complexity and the robustness of network architecture for drug discovery,” Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Maguire, P. Lee, D. Manheim, and L. Boros, “SiDMAP: a metabolomics approach to assess the effects of drug candidates on the dynamic properties of biochemical pathways,” Expert Opinion Drug Discovery, vol. 4, pp. 351–359, 2006. View at Google Scholar
  10. G. Maguire, L. Boros, and P. Lee, “Development of tracer-based metabolomics and its implications for the pharmaceutical industry,” International Journal of Pharmaceutical Medicine, vol. 21, no. 3, pp. 217–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. G. Harrigan, G. Maguire, and L. Boros, “Metabolomics in alcohol research and drug development,” Alcohol Research & Health, vol. 31, no. 1, pp. 26–35, 2008. View at Google Scholar · View at Scopus
  12. K. Akiyama, C. Chen, D. Wang et al., “Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis,” Cell Stem Cell, vol. 10, no. 5, pp. 544–555, 2012. View at Publisher · View at Google Scholar
  13. S. Massberg, P. Schaerli, I. Knezevic-Maramica et al., “Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues,” Cell, vol. 131, no. 5, pp. 994–1008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Eppler, D. L. Combs, T. D. Henry et al., “A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans,” Clinical Pharmacology and Therapeutics, vol. 72, no. 1, pp. 20–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Krishnamurthy and M. C. Manning, “The stability factor: importance in formulation development,” Current Pharmaceutical Biotechnology, vol. 3, pp. 361–371, 2002. View at Google Scholar
  16. G. Maguire and P. Friedman, “Stem Cell-Based Systems Biology Approach For Developing Therapeutics To Manage Peripheral Pain,” Society for Neuroscience Annual Meeting Abstracts, 2011.
  17. B. Mannini, R. Cascella, M. Zampagni et al., “Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 31, pp. 12479–12484, 2012. View at Google Scholar
  18. A. R. Wyatt, J. J. Yerbury, R. A. Dabbs, and M. R. Wilson, “Roles of extracellular chaperones in amyloidosis,” Journal of Molecular Biology, vol. 421, pp. 499–516, 2012. View at Google Scholar
  19. A. I. Caplan, “Why are MSCs therapeutic? New data: new insight,” Journal of Pathology, vol. 217, no. 2, pp. 318–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. G. E. Kilroy, S. J. Foster, X. Wu et al., “Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors,” Journal of Cellular Physiology, vol. 212, no. 3, pp. 702–709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Mannini, R. Cascella, M. Zampagni et al., “Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, pp. 12479–12484, 2012. View at Google Scholar
  22. H. Sarojini, R. Estrada, H. Lu et al., “PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts,” Journal of Cellular Biochemistry, vol. 104, no. 5, pp. 1793–1802, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Schinköthe, W. Bloch, and A. Schmidt, “In vitro secreting profile of human mesenchymal stem cells,” Stem Cells and Development, vol. 17, no. 1, pp. 199–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Schubert, F. Herrera, R. Cumming et al., “Neural cells secrete a unique repertoire of proteins,” Journal of Neurochemistry, vol. 109, no. 2, pp. 427–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Zvonic, M. Lefevre, G. Kilroy et al., “Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis,” Molecular & Cellular Proteomics, vol. 6, no. 1, pp. 18–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Prinsloo, M. M. Setati, V. M. Longshaw, and G. L. Blatch, “Chaperoning stem cells: a role for heat shock proteins in the modulation of stem cell self-renewal and differentiation?” BioEssays, vol. 31, no. 4, pp. 370–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. X. M. Xu, J. Wang, Z. Xuan et al., “Chaperonins facilitate KNOTTED1 cell-to-cell trafficking and stem cell function,” Science, vol. 333, pp. 1141–1144, 2011. View at Google Scholar
  28. M. R. Hicks, T. V. Cao, D. H. Campbell, and P. R. Standley, “Mechanical strain applied to human fibroblasts differentially regulates skeletal myoblast differentiation,” Journal of Applied Physiology, vol. 113, pp. 465–472, 2012. View at Google Scholar
  29. Y. Dor, J. Brown, O. I. Martinez, and D. A. Melton, “Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation,” Nature, vol. 429, no. 6987, pp. 41–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Chimenti, R. R. Smith, T. S. Li et al., “Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice,” Circulation Research, vol. 106, no. 5, pp. 971–980, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder, “Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms,” American Journal of Physiology, vol. 289, no. 1, pp. F31–F42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Gao, J. E. Dennis, R. F. Muzic, M. Lundberg, and A. I. Caplan, “The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion,” Cells Tissues Organs, vol. 169, no. 1, pp. 12–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Wu and R. C. H. Zhao, “The role of chemokines in mesenchymal stem cell homing to myocardium,” Stem Cell Reviews and Reports, vol. 8, no. 1, pp. 243–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Bonig, G. V. Priestley, M. Wohlfahrt, H. P. Kiem, and T. Papayannopoulou, “Blockade of 6-integrin reveals diversity in homing patterns among human, baboon, and murine cells,” Stem Cells and Development, vol. 18, no. 6, pp. 839–844, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Z. Ratajczak, C. H. Kim, A. Abdel-Latif et al., “A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients,” Leukemia, vol. 26, no. 1, pp. 63–72, 2012. View at Google Scholar
  36. C. Mias, E. Trouche, M. H. Seguelas et al., “Ex vivo pretreatment with melatonin improves survival, proangiogenic/ mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney,” Stem Cells, vol. 26, no. 7, pp. 1749–1757, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Fu and H. Li, “Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions,” Cell and Tissue Research, vol. 335, no. 2, pp. 317–321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ilancheran, Y. Moodley, and U. Manuelpillai, “Human fetal membranes: a source of stem cells for tissue regeneration and repair?” Placenta, vol. 30, no. 1, pp. 2–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Trivedi and P. Hematti, “Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells,” Experimental Hematology, vol. 36, no. 3, pp. 350–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Zhang, “Mesenchymal stem cells in cancer: friends or foes,” Cancer Biology and Therapy, vol. 7, no. 2, pp. 252–254, 2008. View at Google Scholar · View at Scopus
  41. G. E. Kilroy, S. J. Foster, X. Wu et al., “Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors,” Journal of Cellular Physiology, vol. 212, no. 3, pp. 702–709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Bochev, G. Elmadjian, D. Kyurkchiev et al., “Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro,” Cell Biology International, vol. 32, no. 4, pp. 384–393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. B. L. Yen, C. J. Chang, Y. C. Chen et al., “Brief report—human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes,” Stem Cells, vol. 27, no. 2, pp. 451–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Bartholomew, C. Sturgeon, M. Siatskas et al., “Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo,” Experimental Hematology, vol. 30, no. 1, pp. 42–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. S. F. Mause and C. Weber, “Microparticles: protagonists of a novel communication network for intercellular information exchange,” Circulation Research, vol. 107, no. 9, pp. 1047–1057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Théry, “Exosomes: secreted vesicles and intercellular communications,” F1000 Biology Reports, vol. 3, no. 1, article 15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Mathivanan and R. J. Simpson, “ExoCarta: a compendium of exosomal proteins and RNA,” Proteomics, vol. 9, no. 21, pp. 4997–5000, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Barile, M. Gherghiceanu, L. M. Popescu, T. Moccetti, G. Vassallib, and I. D. Article, “Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 354605, 10 pages, 2012. View at Publisher · View at Google Scholar
  49. S. Sahoo, E. Klychko, T. Thorne et al., “Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity,” Circulation Research, vol. 109, pp. 724–728, 2011. View at Google Scholar
  50. P. Lu, L. L. Jones, E. Y. Snyder, and M. H. Tuszynski, “Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury,” Experimental Neurology, vol. 181, pp. 115–129, 2003. View at Google Scholar
  51. A. Nasef, A. Chapel, C. Mazurier et al., “Identification of IL-10 and TGF-β transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells,” Gene Expression, vol. 13, no. 4-5, pp. 217–226, 2007. View at Google Scholar · View at Scopus
  52. K. English, F. P. Barry, C. P. Field-Corbett, and B. P. Mahon, “IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells,” Immunology Letters, vol. 110, no. 2, pp. 91–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Sato, K. Ozaki, I. Oh et al., “Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells,” Blood, vol. 109, no. 1, pp. 228–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo, “Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation,” Blood, vol. 103, no. 12, pp. 4619–4621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Plumas, L. Chaperot, M. J. Richard, J. P. Molens, J. C. Bensa, and M. C. Favrot, “Mesenchymal stem cells induce apoptosis of activated T cells,” Leukemia, vol. 19, no. 9, pp. 1597–1604, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. J. A. Potian, H. Aviv, N. M. Ponzio, J. S. Harrison, and P. Rameshwar, “Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens,” Journal of Immunology, vol. 171, no. 7, pp. 3426–3434, 2003. View at Google Scholar · View at Scopus
  58. S. H. Yang, M. J. Park, I. H. Yoon et al., “Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10,” Experimental & Molecular Medicine, vol. 41, no. 5, pp. 315–324, 2009. View at Google Scholar
  59. S. Asari, S. Itakura, K. Ferreri et al., “Mesenchymal stem cells suppress B-cell terminal differentiation,” Experimental Hematology, vol. 37, no. 5, pp. 604–615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. I. Rasmusson, K. Le Blanc, B. Sundberg, and O. Ringdén, “Mesenchymal stem cells stimulate antibody secretion in human B cells,” Scandinavian Journal of Immunology, vol. 65, no. 4, pp. 336–343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Ramasamy, H. Fazekasova, E. W. F. Lam, I. Soeiro, G. Lombardi, and F. Dazzi, “Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle,” Transplantation, vol. 83, no. 1, pp. 71–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Djouad, L. M. Charbonnier, C. Bouffi et al., “Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism,” Stem Cells, vol. 25, no. 8, pp. 2025–2032, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. G. M. Spaggiari, H. Abdelrazik, F. Becchetti, and L. Moretta, “MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2,” Blood, vol. 113, no. 26, pp. 6576–6583, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. Selmani, A. Naji, E. Gaiffe et al., “HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells,” Transplantation, vol. 87, no. 9, supplement, pp. S62–S66, 2009. View at Google Scholar · View at Scopus
  65. G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation,” Blood, vol. 107, no. 4, pp. 1484–1490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. L. A. Ortiz, M. DuTreil, C. Fattman et al., “Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11002–11007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Raffaghello, G. Bianchi, M. Bertolotto et al., “Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche,” Stem Cells, vol. 26, no. 1, pp. 151–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. G. Ren, L. Zhang, X. Zhao et al., “Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide,” Cell Stem Cell, vol. 2, no. 2, pp. 141–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Xu, J. Yan, D. Chen et al., “Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats,” Transplantation, vol. 82, no. 7, pp. 865–875, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Corti, F. Locatelli, D. Papadimitriou et al., “Neural stem cells LewisX + CXCR4 + modify disease progression in an amyotrophic lateral sclerosis model,” Brain, vol. 130, no. 5, pp. 1289–1305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Lu, L. L. Jones, E. Y. Snyder, and M. H. Tuszynski, “Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury,” Experimental Neurology, vol. 181, no. 2, pp. 115–129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Yan, A. M. Welsh, S. H. Boka, E. Y. Snyder, and V. E. Koliatsos, “Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord,” Journal of Comparative Neurology, vol. 480, no. 1, pp. 101–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Crigler, R. C. Robey, A. Asawachaicharn, D. Gaupp, and D. G. Phinney, “Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis,” Experimental Neurology, vol. 198, no. 1, pp. 54–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. M. H. Tuszynski, “Nerve growth factor gene therapy in Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 21, no. 2, pp. 179–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. J. Kim, H. J. Park, G. Lee et al., “Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action,” GLIA, vol. 57, no. 1, pp. 13–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. I. Zwart, A. J. Hill, F. Al-Allaf et al., “Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model,” Experimental Neurology, vol. 216, no. 2, pp. 439–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. H. J. Kim, J. H. Lee, and S. H. Kim, “Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis,” Journal of Neurotrauma, vol. 27, no. 1, pp. 131–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Arien-Zakay, S. Lecht, M. M. Bercu et al., “Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors,” Experimental Neurology, vol. 216, no. 1, pp. 83–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. A. P. Croft and S. A. Przyborski, “Mesenchymal stem cells expressing neural antigens instruct a neurogenic cell fate on neural stem cells,” Experimental Neurology, vol. 216, no. 2, pp. 329–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Li, J. Chen, C. L. Zhang et al., “Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells,” GLIA, vol. 49, no. 3, pp. 407–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. Q. Chen, Y. Long, X. Yuan et al., “Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors,” Journal of Neuroscience Research, vol. 80, no. 5, pp. 611–619, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Wislet-Gendebien, F. Bruyère, G. Hans, P. Leprince, G. Moonen, and B. Rogister, “Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4,” BMC Neuroscience, vol. 5, article 33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Barzilay, T. Ben-Zur, O. Sadan et al., “Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice,” Translational Psychiatry, vol. 1, article e61, 2011. View at Google Scholar
  84. M. Perez-Ilzarbe, O. Agbulut, B. Pelacho et al., “Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium,” European Journal of Heart Failure, vol. 10, no. 11, pp. 1065–1072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. L. B. Balsam, A. J. Wagers, J. L. Christensen, T. Kofidis, I. L. Weissmann, and R. C. Robbins, “Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium,” Nature, vol. 428, no. 6983, pp. 668–673, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. C. E. Murry, M. H. Soonpaa, H. Reinecke et al., “Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts,” Nature, vol. 428, no. 6983, pp. 664–668, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. N. Noiseux, M. Gnecchi, M. Lopez-Ilasaca et al., “Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation,” Molecular Therapy, vol. 14, no. 6, pp. 840–850, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Takahashi, T. S. Li, R. Suzuki et al., “Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury,” American Journal of Physiology, vol. 291, no. 2, pp. H886–H893, 2006. View at Google Scholar
  89. R. Uemura, M. Xu, N. Ahmad, and M. Ashraf, “Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling,” Circulation Research, vol. 98, no. 11, pp. 1414–1421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Xu, R. Uemura, Y. Dai, Y. Wang, Z. Pasha, and M. Ashraf, “In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 2, pp. 441–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Kubal, K. Sheth, B. Nadal-Ginard, and M. Galinanes, “Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans,” The Journal of Thoracic and Cardiovascular Surgery, vol. 132, no. 5, pp. 1112–1118, 2006. View at Google Scholar
  92. M. Korf-Klingebiel, T. Kempf, T. Sauer et al., “Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction,” European Heart Journal, vol. 29, no. 23, pp. 2851–2858, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. D. K. Singla, G. E. Lyons, and T. J. Kamp, “Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling,” American Journal of Physiology, vol. 293, no. 2, pp. H1308–H1314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Huang, H. Gu, Q. Yu, M. C. Manukyan, J. A. Poynter, and M. Wang, “Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion,” PLoS ONE, vol. 6, no. 12, Article ID e29246, 2011. View at Google Scholar
  95. H. Hwang, W. Chang, B. Song et al., “Antiarrhythmic potential of mesenchymal stem cell is modulated by hypoxic environment,” Journal of the American College of Cardiology, vol. 60, no. 17, pp. 1698–1706, 2012. View at Publisher · View at Google Scholar
  96. K. Schenke-Layland, B. M. Strem, M. C. Jordan et al., “Adipose tissue-derived cells improve cardiac function following myocardial infarction,” Journal of Surgical Research, vol. 153, no. 2, pp. 217–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. X. Xu, Z. Xu, Y. Xu, and G. Cui, “Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats,” Coronary Artery Disease, vol. 16, no. 4, pp. 245–255, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Ohnishi, T. Yasuda, S. Kitamura, and N. Nagaya, “Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells,” Stem Cells, vol. 25, no. 5, pp. 1166–1177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Ohnishi, H. Sumiyoshi, S. Kitamura, and N. Nagaya, “Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions,” FEBS Letters, vol. 581, no. 21, pp. 3961–3966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Mureli, C. P. Gans, D. J. Bare, D. L. Geenen, N. M. Kumar, and K. Banach, “Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling,” American Journal of Physiology, vol. 304, no. 4, pp. 600–609, 2013. View at Google Scholar
  101. N. Dib, R. E. Michler, F. D. Pagani et al., “Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up,” Circulation, vol. 112, no. 12, pp. 1748–1755, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Lau, R. Paus, S. Tiede, P. Day, and A. Bayat, “Exploring the role of stem cells in cutaneous wound healing,” Experimental Dermatology, vol. 18, no. 11, pp. 921–933, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. Wu, L. Chen, P. G. Scott, and E. E. Tredget, “Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis,” Stem Cells, vol. 25, no. 10, pp. 2648–2659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. M. P. Zimber, J. N. Mansbridge, M. Taylor et al., “Human cell-conditioned media produced under embryonic-like conditions result in improved healing time after laser resurfacing,” Aesthetic Plastic Surgery, vol. 36, no. 2, pp. 431–437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. D. C. Wan, M. D. Kwan, D. M. Gupta et al., “Global age-dependent differences in gene expression in response to calvarial injury,” Journal of Craniofacial Surgery, vol. 19, no. 5, pp. 1292–1301, 2008. View at Google Scholar
  106. Y. Otsuka-Tanaka, S. Oommen, M. Kawasaki et al., “Oral lining mucosa development depends on mesenchymal microRNAs,” Journal of Dental Research, vol. 92, no. 3, pp. 229–234, 2013. View at Google Scholar
  107. P. J. Murray, P. K. Maini, M. V. Plikus, C.-M. Chuong, and R. E. Baker, “Modelling hair follicle growth dynamics as an excitable medium,” vol. 8, no. 12, Article ID e1002804, 2012. View at Publisher · View at Google Scholar
  108. P. S. Myung, M. Takeo, M. Ito, and R. P. Atit, “Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration,” Journal of Investigative Dermatology, vol. 133, no. 1, pp. 31–41, 2012. View at Publisher · View at Google Scholar
  109. C. Blanpain and E. Fuchs, “Epidermal homeostasis: a balancing act of stem cells in the skin,” Nature Reviews Molecular Cell Biology, vol. 10, no. 3, pp. 207–217, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. N. Li and H. Clevers, “Coexistence of quiescent and active adult stem cells in mammals,” Science, vol. 327, no. 5965, pp. 542–545, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. X. Yan and D. M. Owens, “The skin: a home to multiple classes of epithelial progenitor cells,” Stem Cell Reviews, vol. 4, no. 2, pp. 113–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Guo and L. A. DiPietro, “Factors affecting wound healing,” Journal of Dental Research, vol. 89, no. 3, pp. 219–229, 2010. View at Google Scholar
  113. Y. D. Teng, D. Yu, A. E. Ropper et al., “Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research,” Current Neuropharmacology, vol. 9, no. 4, pp. 574–585, 2011. View at Google Scholar
  114. N. Rao, S. Evans, D. Stewart et al., “Fibroblasts influence muscle progenitor differentiation and alignment in contact independent and dependent manners in organized co-culture devices,” Biomedical Microdevices, vol. 15, no. 1, pp. 161–169, 2013. View at Google Scholar
  115. T. M. Hammoudi, C. A. Rivet, M. L. Kemp, H. Lu, and J. S. Temenoff, “Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes,” Tissue Engineering A, vol. 18, pp. 1686–1697, 2012. View at Google Scholar
  116. V. W. Wong, B. Levi, J. Rajadas, M. T. Longaker, and G. C. Gurtner, “Stem cell niches for skin regeneration,” International Journal of Biomaterials, vol. 2012, Article ID 926059, 8 pages, 2012. View at Publisher · View at Google Scholar
  117. W. S. Kim, B. S. Park, and J. H. Sung, “The wound-healing and antioxidant effects of adipose-derived stem cells,” Expert Opinion on Biological Therapy, vol. 9, no. 7, pp. 879–887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. C. Widmer, J. M. Gebauer, E. Brunstein et al., “Molecular basis for the action of the collagen-specific chaperone Hsp47/SERPINH1 and its structure-specific client recognition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 33, pp. 13243–13247, 2012. View at Google Scholar
  119. Y. Tamura, T. Torigoe, K. Kukita et al., “Heat-shock proteins as endogenous ligands building a bridge between innate and adaptive immunity,” Immunotherapy, vol. 4, no. 8, pp. 841–852, 2012. View at Google Scholar
  120. P. W. Lewis, S. J. Elsaesser, K. M. Noh, S. C. Stadler, and C. D. Allis, “Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14075–14080, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. J. J. Yerbury, E. M. Stewart, A. R. Wyatt, and M. R. Wilson, “Quality control of protein folding in extracellular space,” EMBO Reports, vol. 6, no. 12, pp. 1131–1136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  122. N. E. Sharpless and R. A. DePinho, “How stem cells age and why this makes us grow old,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 703–713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. A. Waterstrat and G. Van Zant, “Effects of aging on hematopoietic stem and progenitor cells,” Current Opinion in Immunology, vol. 21, no. 4, pp. 408–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. H. Toledano, C. D’Alterio, B. Czech, E. Levine, and D. L. Jones, “The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche,” Nature, vol. 485, pp. 605–610, 2012. View at Google Scholar
  125. Y. Guo, B. Graham-Evans, and H. E. Broxmeyer, “Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells,” Stem Cells, vol. 24, no. 4, pp. 850–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. R. E. Davey and P. W. Zandstra, “Spatial organization of embryonic stem cell responsiveness to autocrine Gp130 ligands reveals an autoregulatory stem cell niche,” Stem Cells, vol. 24, no. 11, pp. 2538–2548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. I. Flores, M. L. Cayuela, and M. A. Blasco, “Effects of telomerase and telomere length on epidermal stem cell behavior,” Science, vol. 309, no. 5738, pp. 1253–1256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Collins, V. Renault, L. A. Grobler et al., “Athletes with exercise-associated fatigue have abnormally short muscle DNA telomeres,” Medicine and Science in Sports and Exercise, vol. 35, no. 9, pp. 1524–1528, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. C. He, M. C. Bassik, V. Moresi et al., “Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis,” Nature, vol. 481, pp. 511–515, 2012. View at Google Scholar
  130. M. C. Valero, H. D. Huntsman, J. Liu, K. Zou, and M. D. Boppart, “Eccentric exercise facilitates mesenchymal stem cell appearance in skeletal muscle,” PLoS ONE, vol. 7, no. 1, Article ID e29760, 2012. View at Publisher · View at Google Scholar
  131. A. Carrel and C. A. Lindbergh, The Culture of Organs, Paul Hoeber, New York, NY, USA, 1938.